Leila Ghalichi

Leila Ghalichi

Auto-generated profile, based on publicly available information

Leila Ghalichi

Department of Applied Health Sciences, University of Birmingham, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2014 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
OPOmid Pournik
Omid Pournik
SASeyed Moayed Alavian
Seyed Moayed Alavian
LGLeila Ghalichi
Leila Ghalichi
BSBahram Seifizarei
Bahram Seifizarei
LMLeila Mehrnoush
Leila Mehrnoush
SESaeid Eslami
Saeid Eslami
Background: Histopathologic assessment of liver tissue is an essential step in management and follow-up of non-alcoholic fatty liver disease (NAFLD) while inter- and intra-observer variations limit the accuracy of these assessments. Objectives: The aim of this study was to assess the inter- and intra-observer reproducibility of histopathologic assessment of liver biopsies based on NAFLD activity score (NAS) scoring system. Materials and Methods: The anonymous liver biopsy samples of 100 consecutive NAFLD suspected adults were randomly assigned to four pathologists. Then, the samples were randomly reassigned to the pathologists for the second time in a way that each sample would be evaluated by two different pathologists. Biopsies were revisited by their first evaluator after two months. The results were reported based on NAS scoring system. Results: Inter-observer agreement of the pathology scores based on NAS scoring system was acceptable for steatosis, lobular inflammation, and fibrosis, but not for hepatocyte ballooning. The intra-observer agreement was acceptable in all scales, with lowest intra-class correlation observed for lobular inflammation. Conclusions: NAS scoring system has good overall inter- and intra-observer agreement, but more attention should be given to defining the hepatocyte ballooning and lobular inflammation, and training the pathologists to improve the accuracy of pathology reports. Keywords: Fatty Liver; Observer Variation; Pathology

26 August 2008 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
RKR Karkhaneh
R Karkhaneh
SMS Z Mousavi
S Z Mousavi
MRM Riazi-Esfahani
M Riazi-Esfahani
SES A Ebrahimzadeh
S A Ebrahimzadeh
RRR Roohipoor
R Roohipoor
MMM R Mansouri
M R Mansouri
Aim: To determine the incidence and risk factors of retinopathy of prematurity (ROP) in premature infants referred to a tertiary eye hospital during 2003–7 to provide preliminary evidence about ROP in Iran. Methods: In a cross-sectional study, data for premature infants screened for ROP in Farabi Eye Hospital including possible risk factors and eye exams’ results were recorded and analysed using χ2, univariate and multiple regressions. Severe ROP was defined as ROP needing treatment or stage 4 or 5 of ROP. Results: Among 953 premature infants, there were 329 (34.5%) different stages of ROP. Severe ROP was seen in 22.6% (215/953) of infants (16.5%: treatable, 6.1%: advanced untreatable). The mean gestational age (GA) and birth weight (BW) of infants with severe ROP were 28.8 (SD 2.4) weeks and 1256 (389) g respectively. Univariate analysis showed a significant relation between GA, BW, oxygen therapy, blood transfusion and ROP (p<0.001), while multiple-regression methods showed GA, BW and oxygen therapy as independent predictors of ROP (p<0.001, 0.019 and 0.033, respectively). Conclusion: The authors observed a relatively high incidence of ROP in this series, especially its severe form affecting relatively more mature infants, which merits further investigation. GA, BW and oxygen therapy were independent ROP determinants.

30 September 2016 in BioImpacts
Verified
Journal Article
Open access
MAMohammad Amir Amirkhani
Mohammad Amir Amirkhani
ASAlireza Shoae-Hassani
Alireza Shoae-Hassani
MSMasoud Soleimani
Masoud Soleimani
SHSomayeh Hejazi
Somayeh Hejazi
LGLeila Ghalichi
Leila Ghalichi
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
Introduction: The rejuvenation characteristics of fat tissue grafting has been established for many years. Recently it has been shown that stromal vascular fraction (SVF) of fat tissue contributes to its rejuvenation properties. As the SVF is a minimal processed cell population (based on FDA guidance), therefore it is a suitable cell therapy for skin rejuvenation. This clinical trial was aimed to evaluate the ultrastructural improvement of aging skin in the facial nasolabial region after transplantation of autologous SVF. Methods: Our study was conducted in 16 patients aged between 38 and 56 years old that were interested in face lifting at first. All of the cases underwent the lipoaspiration procedure from the abdomen for sampling of fat tissue. Quickly, the SVF was harvested from 100 mL of harvested fat tissue and then transplanted at dose of 2.0×107 nucleated cells in each nasolabial fold. The changes in the skin were evaluated using Visioface scanner, skin-scanner DUB, Visioline, and Cutometer with multi probe adopter. Results: By administration of autologous SVF, the elasticity and density of skin were improved significantly. There were no changes in the epidermis density in scanner results, but we noticed a significant increase in the dermis density and also its thickness with enrichment in the vascular bed of the hypodermis. The score of Visioface scanner showed slight changes in wrinkle scores. The endothelial cells and mesenchymal progenitors from the SVF were found to chang the architecture of the skin slightly, but there was not obvious phenotypic changes in the nasolabial grooves. Conclusion: The current clinical trial showed the modification of dermis region and its microvascular bed, but no changes in the density of the epidermis. Our data represent the rejuvenation process of facial skin by improving the dermal architecture.

10 September 2017 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
STSeyed Mohammad Tabatabaee
Seyed Mohammad Tabatabaee
SASeyed Moayed Alavian
Seyed Moayed Alavian
LGLeila Ghalichi
Leila Ghalichi
MMMohammad Miryounesi
Mohammad Miryounesi
KMKazem Mousavizadeh
Kazem Mousavizadeh
MVMohammadreza Vafa
Mohammadreza Vafa
Objectives: Antioxidant treatment with Iron chelating agents is one of the suggested treatments for fatty liver disease, which has become an important health problem in the recent decades. In this study the authors evaluated the general antioxidant, iron chelating, and sugar and fat absorption characteristics of green tea. Methods: Patients with non-alcoholic fatty liver disease were randomly assigned to 2 groups for a double blind clinical trial. Patients in the intervention group received 550 milligrams of green tea tablets daily as well as nutritional education for 3 months. The control group received the same protocol with green tea replaced with placebo tablets. Results: After 3 months, 45 participants (21 in the intervention and 24 in the placebo group) completed the follow-up. The change in body mass index (BMI), aspartate aminotransferase (AST), and fasting blood sugar (FBS) was significantly different between the 2 groups, while the change in total iron binding capacity (TIBC), ferritin, alanine transaminase (ALT), HOMA, and weight did not show a significant difference. Conclusions: The difference between the 2 groups was mainly observed in anthropometrics, liver enzyme, and metabolic indicators, although the difference might not have been highlighted due to the effectiveness of routine treatments, that both groups received. Keywords: Green Tea; NAFLD; Iron

1 February 2013
Verified
Journal Article
Closed access
LGLeila Ghalichi
Leila Ghalichi
OPOmid Pournik
Omid Pournik
MGMostafa Ghaffari
Mostafa Ghaffari
EVEva Vingard
Eva Vingard

4 April 2024 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
EGEqui-Injury Group
Equi-Injury Group
JDJustine Davies
Justine Davies
KCKathryn Chu
Kathryn Chu
STStephen Tabiri
Stephen Tabiri
JBJean Claude Byiringiro
Jean Claude Byiringiro
ATAhmed Tanweer
Ahmed Tanweer
Background: Equitable access to quality care after injury is an essential step for improved health outcomes in low- and middle-income countries (LMICs). We introduce the Equi-Injury project, in which we will use integrated frameworks to understand how to improve equitable access to quality care after injury in four LMICs: Ghana, Pakistan, Rwanda and South Africa. Methods: This project has 5 work packages (WPs) as well as essential cross-cutting pillars of community engagement, capacity building and cross-country learning. In WP1, we will identify needs, barriers, and facilitators to impactful stakeholder engagement in developing and prioritising policy solutions. In WP2, we will collect data on patient care and outcomes after injuries. In WP3, we will develop an injury pathway model to understand which elements in the pathway of injury response, care and treatment have the biggest impact on health and economic outcomes. In WP4, we will work with stakeholders to gain consensus on solutions to address identified issues; these solutions will be implemented and tested in future research. In WP5, in order to ascertain where learning is transferable across contexts, we will identify which outcomes are shared across countries. The study has received approval from ethical review boards (ERBs) of all partner countries in South Africa, Rwanda, Ghana, Pakistan and the University of Birmingham. Discussion: This health system evaluation project aims to provide a deeper understanding of injury care and develop evidence-based interventions within and across partner countries in four diverse LMICs. Strong partnership with multiple stakeholders will facilitate utilisation of the results for the co-development of sustainable interventions.